News & Updates

Treatment with a combination of the recombinant human IgG1 monoclonal antibodies casirivimab and imdevimab reduced hospitalization rates in high-risk patients with mild-to-moderate COVID-19, according to results of a retrospective study.

High-flowrate air samplers are able to detect airborne SARS-CoV-2 in hospitals, outperforming even surface sampling, according to a recent Singapore study. Factors such as the site of deployment and distance of the air samplers from patients affect the viral load detected.

COVID-19 does not appear to result in long-term impairment of lung function in children and adolescents, according to two studies presented at ERS 2021.